These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23764749)

  • 1. Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Nosho K; Baba H
    Br J Cancer; 2013 Jul; 109(2):408-15. PubMed ID: 23764749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
    Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
    Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
    Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer.
    Matsunoki A; Kawakami K; Kotake M; Kaneko M; Kitamura H; Ooi A; Watanabe G; Minamoto T
    BMC Cancer; 2012 Dec; 12():574. PubMed ID: 23216958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.
    Konishi K; Watanabe Y; Shen L; Guo Y; Castoro RJ; Kondo K; Chung W; Ahmed S; Jelinek J; Boumber YA; Estecio MR; Maegawa S; Kondo Y; Itoh F; Imawari M; Hamilton SR; Issa JP
    PLoS One; 2011; 6(11):e27889. PubMed ID: 22132162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis.
    Hur K; Cejas P; Feliu J; Moreno-Rubio J; Burgos E; Boland CR; Goel A
    Gut; 2014 Apr; 63(4):635-46. PubMed ID: 23704319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Ogino S; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS
    Int J Cancer; 2008 Jun; 122(12):2767-73. PubMed ID: 18366060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
    Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
    Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
    Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.
    Knijn N; Mekenkamp LJ; Klomp M; Vink-Börger ME; Tol J; Teerenstra S; Meijer JW; Tebar M; Riemersma S; van Krieken JH; Punt CJ; Nagtegaal ID
    Br J Cancer; 2011 Mar; 104(6):1020-6. PubMed ID: 21364579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
    Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
    Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.
    Baba Y; Huttenhower C; Nosho K; Tanaka N; Shima K; Hazra A; Schernhammer ES; Hunter DJ; Giovannucci EL; Fuchs CS; Ogino S
    Mol Cancer; 2010 May; 9():125. PubMed ID: 20507599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer.
    Antelo M; Balaguer F; Shia J; Shen Y; Hur K; Moreira L; Cuatrecasas M; Bujanda L; Giraldez MD; Takahashi M; Cabanne A; Barugel ME; Arnold M; Roca EL; Andreu M; Castellvi-Bel S; Llor X; Jover R; Castells A; Boland CR; Goel A
    PLoS One; 2012; 7(9):e45357. PubMed ID: 23049789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
    Neumann J; Wehweck L; Maatz S; Engel J; Kirchner T; Jung A
    Virchows Arch; 2013 Oct; 463(4):509-23. PubMed ID: 23934607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.